14C Enabled Drug Development
Our unrivalled expertise in 14C radiolabelled drug delivery adds value to your early drug development programmes.
- We provide world-leading expertise in traditional and light-label human ADME studies to generate human metabolism data early in clinical development programmes.
- Microdosing studies.
- ivMicrotracer™ studies generate rapid, low cost IV/PK and absolute bioavailability data.
- We offer a unique Synthesis-to-Clinic™ platform, a fully integrated service to speed up drug development.
